Trials / Completed
CompletedNCT05155072
Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics After Oral Administration of DW1903, DW1903-R1 and DW1903-R2 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open-label, Oral in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW1903 | DW1903 |
| DRUG | DW1903-R1 | DW1903-R1 |
| DRUG | DW1903-R2 | DW1903-R2 |
Timeline
- Start date
- 2020-05-15
- Primary completion
- 2020-09-07
- Completion
- 2020-09-07
- First posted
- 2021-12-13
- Last updated
- 2021-12-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05155072. Inclusion in this directory is not an endorsement.